Clinical Trials Logo

Hyperlipidemias clinical trials

View clinical trials related to Hyperlipidemias.

Filter by:

NCT ID: NCT00114855 Completed - Hyperlipidemia Clinical Trials

The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose

Start date: March 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine to what degree Hypocol® (Red Yeast Rice) may lower low density lipoprotein (LDL)-cholesterol in a European population. The effect of Red Yeast Rice on fasting blood glucose and inflammatory markers will also be investigated.

NCT ID: NCT00109603 Completed - HIV Infections Clinical Trials

Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy

Start date: May 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effect of the anti-HIV drug tenofovir disoproxil fumarate (TDF) on lipid levels in HIV infected adults on stable anti-HIV drug therapy. Study hypothesis: The addition of TDF to stable background antiretroviral therapy in HIV infected individuals with dyslipidemia will result in a reduction of non-HDL after 12 weeks of treatment.

NCT ID: NCT00108485 Terminated - Clinical trials for Diabetes Mellitus, Type 2

Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy

Start date: April 2005
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to test the effectiveness and tolerability of Niaspan® to improve the levels of blood fats ("good" and "bad" cholesterol and triglyceride levels) in people who have kidney damage due to diabetes. A secondary goal is to test whether Niaspan® slows down further development of kidney damage.

NCT ID: NCT00108459 Completed - Obesity Clinical Trials

Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes

Start date: September 2004
Phase: Phase 3
Study type: Interventional

This study is designed to address the hypothesis that in obese patients with type 2 diabetes mellitus (DM), a low carbohydrate diet not specifically restricted in calories compared to low fat, caloric restricted diet over 24 months will cause 5% greater reduction in body weight in patients with obesity and type 2 DM, be safe, and will not have any detrimental effects on serum lipid concentrations.

NCT ID: NCT00106236 Completed - Hypertension Clinical Trials

Efficacy of Exercise at a Fitness Club for Cardiovascular Risk Reduction

Start date: April 2003
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is to determine whether exercise has further beneficial effects on improving cardiovascular risk factors such as hypertension, high cholesterol level or diabetes mellitus, when added to the standard program of health check followed by life style recommendations.

NCT ID: NCT00093899 Completed - Clinical trials for Hypercholesterolemia

A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

Start date: November 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the cholesterol lowering effects of an investigational drug in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).

NCT ID: NCT00092573 Completed - Clinical trials for Hypercholesterolemia

Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

Start date: April 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the cholesterol lowering safety and effectiveness of two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).

NCT ID: NCT00092560 Completed - Clinical trials for Hypercholesterolemia

Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

Start date: December 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the cholesterol lowering effectiveness and safety of two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).

NCT ID: NCT00090402 Completed - Dementia Clinical Trials

Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease

Start date: April 2004
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the effect of fish oil and the antioxidant alpha lipoic acid on factors in the blood that are associated with the progression of Alzheimer's Disease (AD).

NCT ID: NCT00072891 Completed - Hypertension Clinical Trials

Improving Medication Adherence in Comorbid Conditions

Start date: n/a
Phase: N/A
Study type: Interventional

This study is designed to study how adults with Type 2 Diabetes and either high blood pressure and/or high blood cholesterol manage their treatment regimen. It is also called the Diabetes Management Study. Individuals need to be 40 years of age or older and on oral medication (pills) management for two of the three conditions of interest. They may also be on other treatment such as insulin, diet and/or exercise programs. Individuals will be followed for approximately 12 months. About 1/4 of the persons in the study will receive a telephone counseling program with a nurse focused upon their management of their treatment program.